![July 2023 Labs in Court](https://www.g2intelligence.com/wp-content/uploads/2023/06/July23.LCA_.LabsInCourt-iStock-1314971830-1100x800-1-1080x675.jpg)
July 2023 Labs in Court
Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.
Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.
These three lab testing areas were the main sources of fraud and abuse revealed in the OIG’s latest Semi-Annual Report to Congress.
Congress is renewing its previous efforts to make Medicare reimbursement of pharmacy testing permanent—here’s what that could mean for labs.
While the last few weeks haven’t seen many lab-related enforcement actions, several healthcare companies had to pay big.
Yet, despite these declines, Q1 was neither as bad as expected nor totally devoid of positive signs for the future.